Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-12-01

FDA Approved: ALBUTEROL SULFATE INHALATION — Original Application (Amneal Pharmaceuticals NY LLC)

View source ↗

Summary

FDA approved Amneal's albuterol sulfate inhalation as a generic inhalation product under ANDA 211600 for relief of bronchospasm in reversible obstructive airway…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ALBUTEROL SULFATE INHALATION (Albuterol sulfate)

Snippet

ORIG AP for ALBUTEROL SULFATE INHALATION (ALBUTEROL SULFATE)